FIELD: medicine.
SUBSTANCE: antiseptic preparation is followed by the infiltration of a haemangioma floor with 2% Ropivacaine (up to 1-5 ml/cm2). Then 10-15 minutes later involving progression of vasoconstriction and anaesthesia, the ultrasound-controlled sclerotherapy of the haemangioma follows with using a foam form of 1% sodium tetradecyl sulphate. Besides, vaccination is stated contraindicated throughout the therapy.
EFFECT: effective treatment of haemangiomas accompanied with no complications, including allergic responses, and the good aesthetic effect ensured by avoiding the stage of the haemangioma floor suturing.
1 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MAXILLOFACIAL REGION INFANTILE HEMANGIOMA TREATMENT FOR CHILDREN | 2015 |
|
RU2615284C2 |
| METHOD OF SCLEROTHERAPY FOR FACIAL HEMANGIOMAS | 2010 |
|
RU2471431C2 |
| METHOD FOR TREATING SKIN NEOPLASMS IN CHILDREN NOT OLDER THAN ONE YEAR | 2003 |
|
RU2240159C1 |
| METHOD OF TREATING HEMANGIOMAS OF COMPLICATED ANATOMICAL LOCALISATION | 2011 |
|
RU2465026C1 |
| METHOD OF COMBINED TREATMENT OF COMMON HEMANGIOMAS OF NASAL, ORAL AND HYPOPHARYNGEAL PHARYNX | 2017 |
|
RU2676646C2 |
| METHOD OF TREATING CAVERNOUS HEMANGIOMA OF AIRWAYS | 2011 |
|
RU2486932C2 |
| METHOD OF TREATING HEMANGIOMAS | 2015 |
|
RU2584082C1 |
| COMPOSITION OF THE OINTMENT AND THE METHOD OF TREATMENT OF SUPERFICIALLY LOCATED FORMS OF INFANTILE SKIN HEMANGIOMAS IN CHILDREN WITH ITS HELP | 2022 |
|
RU2800945C1 |
| METHOD OF TREATING SKIN AND SOFT TISSUE HEMANGIOMAS IN INFANTS | 2010 |
|
RU2464053C2 |
| METHOD OF TREATING COMBINED AND CAVERNOUS HEMANGIOMAS | 2012 |
|
RU2517573C2 |
